Literature DB >> 17948033

Chemokines: a new class of neuromodulator?

William Rostène1, Patrick Kitabgi, Stéphane Mélik Parsadaniantz.   

Abstract

Chemokines are not only found in the immune system or expressed in inflammatory conditions: they are constitutively present in the brain in both glial cells and neurons. Recently, the possibility has been raised that they might act as neurotransmitters or neuromodulators. Although the evidence is incomplete, emerging data show that chemokines have several of the characteristics that define neurotransmitters. Moreover, their physiological actions resemble those of neuromodulators in the sense that chemokines usually have few effects by themselves in basal conditions, but modify the induced release of neurotransmitters or neuropeptides. These findings, together with the pharmacological development of agonists and antagonists that are selective for chemokine receptors and can cross the blood-brain barrier, open a new era of research in neuroscience.

Mesh:

Substances:

Year:  2007        PMID: 17948033     DOI: 10.1038/nrn2255

Source DB:  PubMed          Journal:  Nat Rev Neurosci        ISSN: 1471-003X            Impact factor:   34.870


  123 in total

Review 1.  Cytokines and brain excitability.

Authors:  Michael A Galic; Kiarash Riazi; Quentin J Pittman
Journal:  Front Neuroendocrinol       Date:  2011-12-27       Impact factor: 8.606

2.  What are chemokine signalling systems doing in the brain?

Authors:  Richard Miles
Journal:  J Physiol       Date:  2010-11-01       Impact factor: 5.182

Review 3.  Chronic alcohol neuroadaptation and stress contribute to susceptibility for alcohol craving and relapse.

Authors:  George R Breese; Rajita Sinha; Markus Heilig
Journal:  Pharmacol Ther       Date:  2010-10-15       Impact factor: 12.310

Review 4.  Neuroimmunology and neuroepigenetics in the establishment of sex differences in the brain.

Authors:  Margaret M McCarthy; Bridget M Nugent; Kathryn M Lenz
Journal:  Nat Rev Neurosci       Date:  2017-06-22       Impact factor: 34.870

5.  Adolescent intermittent ethanol exposure enhances ethanol activation of the nucleus accumbens while blunting the prefrontal cortex responses in adult rat.

Authors:  W Liu; F T Crews
Journal:  Neuroscience       Date:  2015-02-26       Impact factor: 3.590

6.  Involvement of TRPC channels in CCL2-mediated neuroprotection against tat toxicity.

Authors:  Honghong Yao; Fuwang Peng; Navneet Dhillon; Shannon Callen; Sirosh Bokhari; Lisa Stehno-Bittel; S Omar Ahmad; John Q Wang; Shilpa Buch
Journal:  J Neurosci       Date:  2009-02-11       Impact factor: 6.167

7.  Expression and functional significance of SOCS-1 and SOCS-3 in astrocytes.

Authors:  Hongwei Qin; Sandrine A Niyongere; Sun Jung Lee; Brandi J Baker; Etty N Benveniste
Journal:  J Immunol       Date:  2008-09-01       Impact factor: 5.422

Review 8.  Glia in pathological pain: a role for fractalkine.

Authors:  E D Milligan; E M Sloane; L R Watkins
Journal:  J Neuroimmunol       Date:  2008-06-10       Impact factor: 3.478

9.  CX3CR1 Mediates Nicotine Withdrawal-Induced Hyperalgesia via Microglial P38 MAPK Signaling.

Authors:  Yonghong Ding; Wenhui Shi; Guannan Xie; Ailan Yu; Qinghe Wang; Zongwang Zhang
Journal:  Neurochem Res       Date:  2015-09-19       Impact factor: 3.996

10.  Chemokine CCL5 promotes robust optic nerve regeneration and mediates many of the effects of CNTF gene therapy.

Authors:  Lili Xie; Yuqin Yin; Larry Benowitz
Journal:  Proc Natl Acad Sci U S A       Date:  2021-03-02       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.